Enigma Diagnostics Expands US and European Executive Management
Enigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today four senior appointments for its US and European offices.
Read MoreEnigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today four senior appointments for its US and European offices.
Read MoreAccumetrics Inc the first point-of-care method for measuring platelet reactivity, announces that its market-leading VerifyNow P2Y12 test was one of multiple methods evaluated in the POPular study presented during a Late Breaking Clinical Trials session at the American Heart Association’s annual Scientific Sessions.
Read MoreDxNA, a molecular diagnostics company headquartered in St. George, Utah, announced today that the DxNA GeneSTAT PCR system has successfully completed evaluation studies under the direction of a California laboratory supported by the Joint FAO/IAEA Programme in Food and Agriculture.
Read MoreRates of infection by the 2009 H1N1 influenza virus may have peaked in late October, but the pandemic flu virus continues to be a potential source of illness in all age groups, including the elderly, according to a new report by Quest Diagnostics.
Read MoreIonian Technologies Inc, will continue its efforts to develop a rapid point-of-care diagnostics platform for use in the developing world with supplemental funding from the Bill & Melinda Gates Foundation.
Read More